IMMUNOGLOBULIN A NEPHROPATHY

Clinical trials for IMMUNOGLOBULIN A NEPHROPATHY explained in plain language.

Never miss a new study

Get alerted when new IMMUNOGLOBULIN A NEPHROPATHY trials appear

Sign up with your email to follow new studies for IMMUNOGLOBULIN A NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 4 Completed 2 Terminated 2

New antibody drug enters human testing for serious kidney disease

Disease control Not yet recruiting

This early-stage study aims to test the safety and effects of a new drug called MIL116, which is an antibody designed to target a protein involved in IgA nephropathy. It will first be given to healthy volunteers to check for safety, and then to patients with the kidney disease to…

Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY

Phase: PHASE1, PHASE2 • Sponsor: Beijing Mabworks Biotech Co., Ltd. • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

IMMUNOGLOBULIN A NEPHROPATHY

Get alerted when new IMMUNOGLOBULIN A NEPHROPATHY trials appear

New antibody drug enters human testing for serious kidney disease